5-Chloro-2-Fluoro-4-Iodopyridine | CAS:659731-48-3

We serve 5-Chloro-2-Fluoro-4-Iodopyridine CAS:659731-48-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Chloro-2-Fluoro-4-Iodopyridine

Chemical Name:      5-Chloro-2-Fluoro-4-Iodopyridine
CAS.NO: 659731-48-3
Synonyms:2-Chloro-5-fluoro-4-iodopyridine
Molecular Formula:C5H2ClFIN
Molecular Weight: 257.43200
 
Physical and Chemical Properties:
Density: 2.1±0.1 g/cm3
Melting point:/
Boiling point: 250.8±35.0 °C at 760 mmHg
Flash point:105.5±25.9 °C
Index of Refraction: 1.614
 
Specification:
Appearance:White to light yellow crystal powder
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Pharmaceutical intermediate



Contact us for information like 5-Chloro-2-Fluoro-4-Iodopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-5-fluoro-4-iodopyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Chloro-2-Fluoro-4-Iodopyridine Use and application,2-Chloro-5-fluoro-4-iodopyridine technical grade,usp/ep/jp grade.


Related News: The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.(R)-(-)-1-Aminoindan manufacturer Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.Cyclomethicone supplier The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.3-phenylmethoxypyridin-2-amine vendor The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.